OMERS ADMINISTRATION Corp Buys Shares of 20,057 Danaher Corporation (DHR)
OMERS ADMINISTRATION Corp bought a new stake in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 20,057 shares of the conglomerate’s stock, valued at approximately $1,693,000.
Other institutional investors have also modified their holdings of the company. Lee Danner & Bass Inc. boosted its position in shares of Danaher Corporation by 0.4% in the 1st quarter. Lee Danner & Bass Inc. now owns 2,635 shares of the conglomerate’s stock worth $225,000 after purchasing an additional 10 shares during the last quarter. Norway Savings Bank grew its stake in shares of Danaher Corporation by 0.4% during the second quarter. Norway Savings Bank now owns 2,238 shares of the conglomerate’s stock worth $189,000 after purchasing an additional 10 shares during the period. First Financial Corp IN grew its stake in shares of Danaher Corporation by 0.8% during the second quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock worth $230,000 after purchasing an additional 21 shares during the period. Brighton Jones LLC grew its stake in shares of Danaher Corporation by 0.4% during the second quarter. Brighton Jones LLC now owns 5,159 shares of the conglomerate’s stock worth $435,000 after purchasing an additional 21 shares during the period. Finally, Guardian Life Insurance Co. of America grew its stake in shares of Danaher Corporation by 1.0% during the first quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock worth $202,000 after purchasing an additional 24 shares during the period. Institutional investors own 75.68% of the company’s stock.
Danaher Corporation (DHR) opened at 86.52 on Wednesday. The company has a market cap of $60.10 billion, a PE ratio of 27.62 and a beta of 1.03. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.62. The firm’s 50-day moving average price is $84.54 and its 200-day moving average price is $84.14.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.90 earnings per share. Equities research analysts forecast that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be given a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.65%. The ex-dividend date is Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is 17.83%.
DHR has been the topic of a number of recent analyst reports. J P Morgan Chase & Co restated an “overweight” rating and set a $95.00 target price on shares of Danaher Corporation in a report on Friday, September 8th. Janney Montgomery Scott lowered Danaher Corporation from a “buy” rating to a “neutral” rating in a research report on Wednesday, June 7th. BidaskClub cut Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Saturday, July 8th. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a research note on Saturday, July 22nd. Finally, Citigroup Inc. set a $96.00 price target on shares of Danaher Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. One analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. Danaher Corporation has a consensus rating of “Buy” and a consensus price target of $91.98.
In other news, insider William King sold 43,688 shares of the stock in a transaction dated Thursday, August 31st. The shares were sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the transaction, the insider now owns 45,748 shares of the company’s stock, valued at approximately $3,790,679.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the transaction, the insider now directly owns 155,520 shares in the company, valued at approximately $12,718,425.60. The disclosure for this sale can be found here. Insiders sold a total of 71,496 shares of company stock valued at $5,916,223 in the last quarter. 12.20% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION WARNING: This piece of content was first posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/omers-administration-corp-buys-shares-of-20057-danaher-corporation-dhr/1606757.html.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.